BlackRock Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$56.5M Sell
481,959
-19,624
-4% -$2.24M 0.03% 574
2016
Q3
$56.5M Sell
501,583
-7,644
-2% -$806K 0.03% 559
2016
Q2
$47.3M Buy
509,227
+379,179
+292% +$32.6M 0.02% 589
2016
Q1
$10.2M Buy
130,048
+53,887
+71% +$3.88M 0.01% 917
2015
Q4
$5.55M Sell
76,161
-44,493
-37% -$3.17M ﹤0.01% 1071
2015
Q3
$8.96M Buy
120,654
+43,644
+57% +$3.13M 0.01% 948
2015
Q2
$4.94M Sell
77,010
-3,694
-5% -$256K ﹤0.01% 1146
2015
Q1
$6.23M Sell
80,704
-26,660
-25% -$2.07M ﹤0.01% 1072
2014
Q4
$7.96M Buy
107,364
+13,792
+15% +$967K ﹤0.01% 1011
2014
Q3
$5.51M Buy
93,572
+52,516
+128% +$3.32M ﹤0.01% 1072
2014
Q2
$2.74M Sell
41,056
-38,476
-48% -$2.45M ﹤0.01% 1333
2014
Q1
$4.83M Buy
79,532
+11,352
+17% +$676K ﹤0.01% 1124
2013
Q4
$3.63M Buy
68,180
+3,332
+5% +$175K ﹤0.01% 1185
2013
Q3
$3.23M Buy
64,848
+740
+1% +$35.6K ﹤0.01% 1235
2013
Q2
$2.88M Buy
+64,108
New +$2.8M ﹤0.01% 1149

Other funds holding IDXX

BlackRock Group's IDXX Position: Q4 2016 in Review

BlackRock Group reduced its Idexx Laboratories (IDXX) stake by 3.9% in Q4 2016, selling an estimated $2.24M and leaving 481,959 shares worth $56.5M. The position accounts for 0.03% of the portfolio, ranked #574.

BlackRock Group first reported a position in IDXX in Q2 2013 and has held it in 15 quarters since. The position peaked at $56.5M in Q3 2016. 523 funds tracked by Wall St. Rank hold IDXX as of Q4 2016.

  • BlackRock Group held 481,959 shares of Idexx Laboratories worth $56.5M as of Q4 2016.
  • BlackRock Group sold 19,624 Idexx Laboratories shares in Q4 2016, an estimated $2.24M.
  • Idexx Laboratories made up 0.03% of BlackRock Group's portfolio in Q4 2016, its #574 holding.
  • BlackRock Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Idexx Laboratories position peaked at $56.5M in Q3 2016.
  • 523 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.